Karl Björkström

Artiklar

Article: EUROPEAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. 2021;33(11):1420-1426
A personalized treatment program in persons with type 2 diabetes is associated with a reduction in liver steatosis
Bjorkstrom K; Stal P; Holmer M; Bengtsson B; Staaf A; Hoffstedt J; Hagstrom H
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2021;56(6):727-732
Etiologies and outcomes of cirrhosis in a large contemporary cohort
Hagstrom H; Lindfors A; Holmer M; Bengtsson B; Bjorkstrom K; Hegmar H; von Seth E
Article: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2019;17(13):2769-2775.e4
Risk Factors for Severe Liver Disease in Patients With Type 2 Diabetes
Bjorkstrom K; Franzen S; Eliasson B; Miftaraj M; Gudbjornsdottir S; Trolle-Lagerros Y; Svensson A-M; Hagstrom H
Article: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2017;15(9):1461-1468
Histologic Scores for Fat and Fibrosis Associate With Development of Type 2 Diabetes in Patients With Nonalcoholic Fatty Liver Disease
Bjorkstrom K; Stal P; Hultcrantz R; Hagstrom H

Medicine Doktorsexamen, Institutionen för medicin, Huddinge, Karolinska Institutet, 2021
Läkarexamen, Karolinska Institutet, 2018